Pathogenesis and treatment of hyperkeratotic tinea pedis in Japan

Mycoses

Volumn 42, Issue 1-2, 1999, Pages 21-28

  Tanuma, H ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hyperkeratosis; Japan; Pathogenesis; Tinea pedis; Treatment

Indexed keywords

ANTIFUNGAL AGENT; BIFONAZOLE; BUTENAFINE; ECONAZOLE; FLUCONAZOLE; GRISEOFULVIN; IMIDAZOLE DERIVATIVE; ITRACONAZOLE; KETOCONAZOLE; LANOCONAZOLE; TERBINAFINE; TIOCONAZOLE; UREA DERIVATIVE;

DRUG EFFICACY; DRUG HALF LIFE; GASTROINTESTINAL DISEASE; HUMAN; HYPERKERATOSIS; JAPAN; LIVER DISEASE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTECTIVE CLOTHING; REVIEW; TINEA PEDIS; TOPICAL DRUG ADMINISTRATION; TRICHOPHYTON RUBRUM;

ANTIFUNGAL AGENTS; HUMANS; JAPAN; KERATOSIS; TINEA PEDIS; TRICHOPHYTON;

TINEA; TRICHOPHYTON RUBRUM;

EID: 0032988795     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0507.1999.00403.x     Document Type: Review

References (49)

1. 1 Takahashi, Y. & Takahashi S. (1961) Trichophytia Pompholyciformis. Japan Dermatology Compendium, X 3. Kanehara Shuppan, pp. 84-120.
2. 2 Takahashi, N, (1969) Dermatophyte phase in out-patients at the department of dermatology, Tohoku University. Jpn. J. Med. Mycol. 10, 11-16.
3. 3 Iwatsu, T., Yanogido, M., Kariyc, H. & Okamoto, S. (1976) Statistical survey of dermatomycoses at the Dermatological Clinic of Chiba University Hospital in the last 10 years. Nishinihon J. Dermatol. 38, 96-102.
4. 4 Takisawa, K. (1982) Tinea Pedis. Modern Dermatology Series, Vol. 7B. Yamamura Y, et al. (eds). Nakayama Shoten, pp. 45-59.
5. 5 Savin, R. C. (1990) Oral Terbinafine versus griseofulvin in the treatment of moccasin-type tinea pedis. J. Am. Acad. Dermatol 23, 807-809.
6. 6 Savin, R. C., Atton, A. V. & Bergstrasser, P. R. (1994) Efficacy of terbinafine 1% cream in the treatment, of moccasin-type tinea pedis: results of placebo-controlled multicenter trials. J. Am. Acad. Dermatol. 30, 663-667.
7. 7 Kagawa, S. (1973) An atlas of mycosis, Iyaku No Mon 13, 362-363.
8. 8 Takahashi, H., Saito, A. & Nishiyama, S. (1993) Effectiveness and safety of lanoeonazole cream for hyperkeratotic tinea pedis. Nishinihon J. Dermatol. 55, 961-971.
9. 9 Terbinafine Study Group. (1994) A double-blind clinical trail of terbinafine comparative with griseofulvin for hyperkeratotic tinea pedis and manus, trichophytosis in hairy areas, Nishinihon J. Dermatol. 56, 844-861.
10. 10 Tanuma, H. (1994) Fungal infections and cytokines. Jpn. J. Dermatol 104, 498.
11. 11 Tanuma, H. (1995) Treatment of hyperkeratotic tinea pedis. Jpn. J. Dermatol. 105, 532.
12. 12 Kashima, M., Takahashi, H., Shimosaka, M., Epstein, W. L. & Fuyuyama, K. (1989) Candidacidal activities of proteins, partially purified from rat epidermis. Infect. Immun. 57, 186-190.
13. 13 Tanuma, H., Iwasaki, M. & Nishiyama, S. (1989) Immunohistochemical studies in fungal diseases of skin. Jpn. J. Dermatol. Series A 99, 1007-1020.
14. 14 Tanuma, H. (1991) Inflammatory dermatological diseases (12)-fungal infections (I): superficial dermatomycosis. Pathol. Clin. Med. 9, 647-652.
15. 15 Miyata, S., Fujimura, T., Masazawa, M. & Katsuoka, K. (1994) Kxpression of IFN-γ mRNA in affected lesions of superficial fungal infection. Jpn. J. Dermatol. Series A 104, 446.
16. 16 Koga, T. (1994) A role of cytokines in cutaneous mycosis. Jpn. J. Dermatol. Series A 104, 506.
17. 17 Koga, T, (1994) Cytokines in cutaneous mycosis. J. Jpn. Soc. Mycol. 35, 56.
18. 18 Kasai, T. (1992) The antimycotic agent. J. Ther. 74, 19-25.
19. 19 Otoyama, K, & Horiuchi, Y. (1991) Tinea ungium and systemic disease. Rinsho Derme Tokyo 33, 239-241.
20. 20 Lambert, D. R., et al. (1989) Griseofulvin and ketoconazole in the treatment of dermatophyte infections. Int. J. Dermatol. 28, 300-304.
21. 21 Itraconazole Research Group in the Field of Dermatology. (1991) Double-blind comparison of itraronazole with griseofulvin in the treatment of dermatophytosis. Clin. Report 25, 103-120.
22. 22 Artis, W. M., Odle, M. B. & Jones, H. E. (1981) Griscofulvin-resistant dermatophytosis correlates with in vitro resistance. Arch. Dermatol. 117, 16-19.
23. 23 Cauwenbergh, G., De Streef, H. & Heykants, I. (1988) Pharmacokinetic profile of orally administered itraconazole in human skin. J. Am. Acad. Dermatol. 18, 263-268.
24. 24 Koguchi, K., Ochide, A. & Obayashi, S. (1991) Phase I study on itraconazole (TTZ), and oral triazole antifungal-pharmacokinetics of ITZ in healthy subjects after single and multiple oral administration. Clin. Report 25, 21-30.
25. 25 Itraconazole Research Group in the Field of Dermatology. (1991) Clinical evaluation of hyperkeratotic tinea pedis and manus, tinea capilis, kerion Celsi and tinea barbae treated with a new oral mycotic agent itraconazole. Clin. Report 25, 47-56.
26. 26 Hay, R. J. (1990) Antifungal drugs an introduction. J. Dermatol. Treat. 1 (Suppl. 2): 1-3.
27. 27 Lever, L. R., Dykes, P. J. & Finaly, A. Y. (1990) How orally administered terbinafine reaches the stratum corneum. J. Dermatol. Treat. 1 (Suppl. 2), 23-25.
28. 28 White, J. E., Perkins, P. S. & Evans E. G. V. (1991) Successful 2-week treatment with terbinafine (Lamisil®) for moccasin tinea pedis and tinea manum. Br. J. Dermatol. 125, 260-262.
29. 29 Savin, R. C. (1989) Successful treatment of chronic tinea pedis (moccasin type) with terbinafine (Lamisil®). Clin. Exp. Dermatol. 14, 116-119.
30. 30 Savin, R. C. (1990) Terbinafine (Lamisil®) versus griseofulvin in moccasin type tinea pedis. J. Dermatol. Treat. 1 (Suppl. 2), 43-46.
31. 31 Savin, R. C. (1990) Oral terbinafine versus griseofulvin in the treatment of moccasin-type tinea pedis. J. Am. Acad. Dermatol. 23, 807-809.
32. 32 Zeid, S. A., Halim, S. (1994) Short term oral lamisil (Terbinafine) iri the treatment of moccasin tinea pedis. J. Pan-Arab League Dermatologist 5, 113-119.
33. 33 Tanuma, H., Doi, M., Yaguchi, A., et al. (1998) Efficacy of oral fluconazole in tinea pedis of the hyperkeratotic type. Stratum corneum levels. Mycoses 41, 153-161.
34. 34 Umezawa, A., Tanuma, H. & Ohrni, M (1985) Clinical evaluations of tioconazole cream for hyperkeratotic tinea pedis and manus. Med. Consult. New Remedies 22, 1603-1605.
35. 35 Greer, D. L. (1987) Topical treatment for moccasin-type tinea pedis. J. Am. Acad. Dermatol 16, 554-558.
36. 36 Tanuma, H., Nakamara, K., Iwasaki, M. & Nishiyama, S. (1989) Clinical evaluation of bifonazole (mycospor solution) for hyperkeratotic-type tinea pedis. Nishinihon J. Dermatol. 51, 1207-1210.
37. 37 Matsumoto, T., Ishizaki, H. & Kasai, T. (1995) Combined treatment of butenafine HCl cream and urea ointment. Nishinihon J. Dermatol. 57, 613-621.
38. 38 Nishikawa, K., Harada, T., Masuda, M., et al. (1990) Combined treatment of KP-363 cream and urea ointment (Urepearl) for hyperkeratotic type tinea pedis. J. New Remedies Clinics 39, 689-698.
39. 39 Ohta, Y., Tanuma, H, Doi, M. & Katsuaka, K. (1996) Study on the treatment of hyperkeratotic-type tinea pcdis by butenafine HCl cream (Mentax®) alone and in combination urea ointments. Nishinihon J. Dermatol. 58, 1033-1037.
40. 40 Savin, R. C., et al. (1994) Efficacy of terbinafine 1% cream in the treatment of moccasin-type tinea pedis: results of placebo-controlled multicenter trials. J. Am. Acad. Dermatol. 30, 663-667.
41. 41 Feldman, R. J. & Maibach, H. (1974) Percutaneous penetration of hydrocortisone with urea. Arch. Dermatol. 109, 58-59.
42. 42 Yamaguchi, M. & Higashiya, M. (1981) Clinical evaluation of econazole cream in combination urepearl for tinea pedis (hyperkeratotic type), and cutaneous mycosis with secondary infection. Igaku To Yakugaku 6, 1783-1789.
43. 43 Doi, H. & Umezawa, A. (1984) Clinical evaluation of econazole nitrate (Palavale®) cream in combination 10% urea ointment (Urepearl®). J. New Remedies Clinics 33, 127-130.
44. 44 Nakamura, K., Chin, K. & Kawana, S, (1993) Clinical efficacy of concomitant administration of oxiconazole nitrate and 20% urea ointment in hyperkeratotic tinea pedis. Clin. Report 27, 4509-4516.
45. 45 Nakajima, T., Sato, H, & Izima, M. (1993) Combination effect of salicylic acid on antifungal activity of tolnaftate preparation (ZM-589), Jpn. J. Med. Mycol. 34, 27-34.
46. 46 Nakajima, T., Nakazawa, C. & Yonara, Y, (1992) Effect of salicylic acid of the penetration of tolnaftate and histological changes in skin. Arch. Pract. Pharmacy, 52, 160-165.
47. 47 Nishimoto, K. & Nakaura, M. (1983) Treatment or hyperkeralotic tinea pedis and manus by antimycotic agent-occlusive dressing technique. Nishinihon J. Dermatol. 45, 454-455.
48. 48 Tanuma, S. & Nishiyama, S. (1997) Clinical evaluation of bifonazole for moccasin type tinea Pedis. mycoses 40, 223-228.
49. 49 Tanuma, H., Doi, M., Ohta, Y., (1999) Usefulness of 1% terbinafine HCl (Lamisil®) cream for hyperkeratotic-type tinea pedis and its transfer into the horny layer. mycoses 42, in press.